Uncle Copyright © 2021. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Over the past six months, the relative strength of its shares against the market has been -5.49%. The Dividend Portfolio on Seeking Alpha | December 30, 2020 Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know Johnson & Johnson (JNJ) closed at $154.14 in the latest trading session, marking a +0.62% move from the prior day. Seeking Alpha - 2 weeks ago Johnson & Johnson Should Have Vaccine And Dividend Tailwinds In 2021 JNJ is a Dow Jones Industrial Average component that makes consumer packaged goods, medical devices, and pharmaceuticals. Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. JNJ's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 37.79% of tickers in our DCF set. Find the latest JNJ210115C00165000 (JNJ210115C00165000) stock quote, history, news and other vital information to help you with your stock trading and investing. The company has produced more trailing twelve month cash flow than 97.59% of its sector Healthcare. Price target in 14 days: 160.084 USD. CNN Sans™ & © 2016 Cable News Network. Most stock quote data provided by BATS. The company was founded in 1885 and is based in New Brunswick, New Jersey. In depth view into JNJ (Johnson & Johnson) stock including the latest price, news, dividend history, earnings information and financials. Don't Over Think It, Buy Johnson & Johnson - Johnson & Johnson (NYSE:JNJ) | Seeking Alpha 2019-10-21 seekingalpha.com - This company certainly doesn't come without risks, but its AAA balance sheet, 57-year dividend growth streak, and reliable cash … The latest closing stock price for Johnson & Johnson as of December 31, 2020 is 157.38.. The optimistic view of market watchers indicates … This assumes a price of $39 per two-shot course or $19.50 per dose. According to Seeking Alpha, the 24 and 60-month beta for JNJ are both 0.70 and 0.72 respectively. Factset: FactSet Research Systems Inc.2019. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Price/Book: A financial ratio used to compare a company's current market price to its book value. Airbnb opens at $146 per share, soaring 114.7% above IPO price Breaking News • Dec 10, 2020 Dow sheds 150+ points, or 0.6%, after jobless claims jump, in sign of virus-related economic softening All rights reserved. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Thibaut Mongon in US:JNJ / Johnson & Johnson. The report begins with the fundamental Oncology Drugs industry review and afterward goes into every single detail. Per one Seeking Alpha commentator, the breakup value of GHC stock could be $700 per share. Why Did Johnson & Johnson Cut the Size of Its Coronavirus Vaccine Trial? In terms of opportunity, JNJ's provides a return of 88.3% based on the forecast of the dividend discount model we used relative to its current share price; this is a better return than 85.52% of all stocks we measured with our dividend discount model. This analysis helps to understand if the insider consistently generates. Johnson & Johnson has a strong presence in emerging markets, including the BRIC countries of Brazil, Russia, India, and China. In terms of volatility of its share price, JNJ is more volatile than only 0.11% of stocks we're observing. Buy JNJ? Analysts surveyed by Seeking Alpha now show that its earnings per share (EPS) will hit $9.46 in 2021. Johnson & Johnson researches and develops, manufactures, and sells various products in the health-care field worldwide. Date Open High Low Close Volume Change % Price/Earnings: Latest closing price divided by the earnings-per-share based on the trailing 12 months. 2019-11-18 seekingalpha.com - 9 - Arrowhead share price has grown by 302% in last year; and 65% in last 3 months alone. 22 hours ago As we can see above, AbbVie's share price growth in the past three months has been second only to Pfizer's (NYSE:PFE), and … Johnson & Johnson (NYSE: JNJ) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on … Historical Prices for Johnson & Johnson (JNJ). Seeking Alpha - Now is an attractive time to add Johnson & Johnson (NYSE:JNJ) to one's portfolio. The company Analyst Actions: Zacks Adjusts Johnson & Johnson's Price Target to $161 from $156, Keeps Neutral Rating 10:49AM ET 12/30/2020 MT Newswires. All Rights Reserved. As for the metrics that stood out in our discounted cash flow analysis of Johnson & Johnson, consider: For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as JNJ, try DYNT, BAX, LNTH, VIVO, and HOLX. 7 days ago Visa (V) is a credit card processing, and the service company is a buy for the total return investor. U. JNJ has a beta that is appropriate for this portfolio. News • Dec 17, 2020. The stock has long been an investors’ favorite, thanks to its solid fundamentals and stable growth. Johnson & Johnson (JNJ) has an average rating of outperform and price targets ranging from $139 to $180, according to analysts polled by Capital IQ. View and compare JNJ, on Yahoo Finance. in Medical - Pharmaceuticals. The Dow Jones closed higher in today's stock market. 7 days ago As I predicted at the time, things are very different now, with the share price buoyant at $106 - albeit still some way short of the $145 long-term price Johnson & Johnson ( JNJ ) EVP, Global Corp Aff & COO Michael E Sneed Sold $8. 6 days ago Altimmune, Inc. (NASDAQ:ALT) is a clinical stage biopharmaceutical company, focused on developing treatments for liver disease, immune modulating therapies, and vaccines. Disclaimer. The business' balance sheet suggests that 8% of the company's capital is sourced from debt; this is greater than merely 22.61% of the free cash flow producing stocks we're observing. At the current price of $157.38, shares in Johnson & Johnson are trading at … 6 days ago Analyst consensus 12-month target price for JNJ is $174, and while I think that might be somewhat high for a stock whose all-time peak ... Johnson & Johnson Vs. Johnson & Johnson Technical Analysis Next reporting date: January 26, 2021: EPS forecast (this quarter) $1.83: Annual revenue (last year) $82.1B: Annual profit (last year) $15.1B: Net profit margin In depth view into JNJ (Johnson & Johnson) stock including the latest price, news, dividend history, earnings information and financials. JNJ targets COVID-19 late-stage trial results by January msn.com - December 8 at 5:25 PM Dow Inc., Johnson & Johnson share gains contribute to Dow's 150-point jump marketwatch.com - December 8 at 5:25 PM It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. © 2020 Cable News Network. The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Johnson & Johnson. Johnson & Johnson will decide if any of the 230 million doses of Covid-19 vaccine scheduled to be produced at Aspen Pharmacare’s Port Elizabeth factory will be sold in the South African market. Seeking Alpha - I have talked about the bullish long-term setup for Johnson & Johnson (JNJ) this year on Seeking Alpha several times. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Johnson & Johnson Stock Price Forecast, JNJ stock price prediction. The stock currently trades for around $450 per share … Ultimately, this should drive the stock price to $190 per share. Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. Johnson & Johnson (JNJ) Stock Price | NasdaqJohnson & Johnson (JNJ) Stock Quote, History and News - Yahoo FinanceJohnson & Johnson (JNJ) Stock Price and Basic Information | MarketWatch. A Warner Media Company. S&P 500, Dow and Nasdaq each rise to record closing highs as traders hold out hope for another stimulus deal Trade Grade This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. All times are ET. Johnson & Johnson (NYSE: JNJ) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on Benzinga. Buy & Hold Grade In 2020, analysts expect Johnson & Johnson to earn $8 a share, minus some items, on $81.8 billion in sales. J&J opened at $130.56 per share Wednesday, up roughly 2% year-to-date. While Merck’s 30x multiple is closer to the … Price trends tend to persist, so it's worth looking at them when it comes to a share like Johnson & Johnson. Get the latest Johnson & Johnson (JNJ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Oncology Drugs Market Report contains inside and out data on significant. If JNJ's one shot offering proves to be anywhere near the efficacy of the two shot options currently available JNJ share price could see $175 in about 6 months time. To summarize, we found that Johnson & Johnson ranked in the 30th percentile in terms of potential gain offered. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. The company has posted stronger-than-expected quarterly earnings consistently in the past. Ian Bezek has written more than 1,000 articles for InvestorPlace.com and Seeking Alpha… BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK This value has as well a bigger second impulse structure activated with target price $228.66 +48% from current price. The Health Care sector is edging higher as investors are taking COVID vaccine and treatment setbacks in stride.The SPDR Health Care Sector … All rights reserved. Now is an attractive time to add Johnson & Johnson (NYSE:JNJ) to one's portfolio. The Dividend Portfolio on Seeking Alpha | December 30, 2020. The all-time high Johnson & Johnson stock closing price was 157.38 on December 31, 2020.; The Johnson & Johnson 52-week high stock price is 157.66, which is 0.2% above the current share price. View real-time stock prices and stock quotes for a full financial overview. Seeking Alpha 1 week ago Johnson & Johnson: Poised For A Blowout 2021 EXPD arrow_upward0.56% Seeking Alpha 3 weeks ago Pfizer Vs. Merck Vs. AbbVie … Could Johnson & Johnson Be a Millionaire-Maker Stock? The company J&J has activated a second impulse structure with target price at $180.35 that is +17% from current price. Discover historical prices for JNJ stock on Yahoo Finance. Don't Overthink It, Buy Johnson & Johnson - Johnson & Johnson (NYSE:JNJ) | Seeking Alpha 2019-10-21 seekingalpha.com - This company certainly doesn't come without risks, but its AAA balance sheet, 57-year dividend growth streak, and reliable cash flows/bottom-line growth give me peace of mind. In addition to company growth, JNJ offers investors dividends and share repurchases to increase total shareholder returns at a rate that exceeds growth of the company. Meanwhile, the other major indexes also rallied after a rough first trading session for 2021 on Monday. Independent on Saturday | January 5, 2021, Oncology Drugs Market Report 2020-2026 incorporates a complete examination of the current market. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Impressively the company has been able to keep overall revenues … With Johnson & Johnson trading in the $150's today, now is a great time to add this … Seeking Alpha - Portfolio Navigator. Date Type Description 01/22/2021 Earnings Johnson & Johnson Fourth Quarter Earnings for • The 4 Best Performing Dow Jones Stocks in 2020, • 4 “Buy” Rated Stocks to Buy for January, • 3 Software Stocks to Snatch Up in 2021: Oracle, EPAM Systems, and Ceridian HCM Holding, Aspen readying to make Johnson & Johnson Covid vaccine, Global Oncology Drugs Market - Competitive Analysis Market 2020 Key Findings, Regional Analysis, Size, Share, Industry Growth | Johnson & Johnson, Pfizer, Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know, Dow Jones Gains 168 Points Amid Georgia Senate Vote; These 4 Stocks Break Out, Johnson & Johnson (JNJ) Stock Price | Nasdaq, Johnson & Johnson (JNJ) Stock Quote, History and News - Yahoo Finance, Johnson & Johnson (JNJ) Stock Price and Basic Information | MarketWatch. Peer Grade Our DCF analysis suggests the stock is overvalued by about 57%. Johnson & Johnson: Accelerating Their Virus Vaccine Development And The Buy Of Momenta With Debt Is A Good Move (NYSE:JNJ) | Seeking Alpha 08-25 seekingalpha.com - Johnson & Johnson has increased its dividend for 58 years in a row (a dividend king) and presently has a yield of 2.7%, which is above average. The firm has 12 "buy" ratings, 11 "hold" ratings, and one "sell" rating, with a consensus price … Companies with negative earnings receive an "NE." Share: Obalon Therapeutics Inc (NASDAQ: OBLN ) shares rose 60 percent Wednesday morning, triggered by a Seeking Alpha post that said Johnson & Johnson (NYSE: JNJ … Value stocks across national boundaries and market caps … It is the most commonly used metric for determining a company's value relative to its earnings. Price to Earnings Ratio or P/E is price / earnings. Visa has steady growth and has plenty of … 6:33am / MotleyFool.com - Paid Partner Content, Jan 05 / MotleyFool.com - Paid Partner Content, 6:08am / MotleyFool.com - Paid Partner Content, Jan 05 / Zacks.com - Paid Partner Content, Jan 04 / MotleyFool.com - Paid Partner Content, Jan 03 / MotleyFool.com - Paid Partner Content, 3 Top Coronavirus Stocks to Buy Right Now, If I Could Buy Only 1 Coronavirus Vaccine Stock, This Would Be It. Below are the latest news stories about Johnson & Johnson that investors may wish to consider to help them evaluate JNJ as an investment opportunity. Stocks with similar financial metrics, market capitalization, and price volatility to Johnson & Johnson are. This is up from a loss of $1.69 in 2020.InvestorPlace - … Johnson & Johnson (JNJ) closed at $158.34 in the latest trading session, marking a +1.18% move from the prior day. Johnson & Johnson (JNJ) Outpaces Stock Market Gains: What You Should Know, Johnson & Johnson Declares Fresh Dividend; Yield Is 2.6%. JNJ | Complete Johnson & Johnson stock news by MarketWatch. Morgan Stanley Raises Johnson & Johnson (NYSE:JNJ) Price Target to $178.00 americanbankingnews.com - December 15 at 1:53 PM: Spain's Reig Jofre to manufacture J&J's COVID-19 vaccine in Barcelona finance.yahoo.com - December 15 at 4:06 AM: Johnson & Johnson Should Have Vaccine And Dividend Tailwinds In 2021 seekingalpha.com - December 14 at 2:42 PM Industry Rank, Ranked of 248 Another data point in favor of Johnson & Johnson is its lower price to free cash flow valuation today. Reply. Seeking Alpha - Johnson & Johnson (NYSE:JNJ) says it has fully enrolled participants for the first late-stage trial of its COVID-19 single-dose vaccine … To see all exchange delays and terms of use, please see disclaimer. 6 days ago Altimmune, Inc. (NASDAQ:ALT) is a clinical stage biopharmaceutical company, focused on developing treatments for liver disease, immune modulating therapies, and vaccines. Earnings would slip 8% and sales be flat. A high-level overview of Johnson & Johnson (JNJ) stock. Seeking Alpha - Probably the greatest discount out there between what you would see as value and price is in REITs and real estate securities. On the date of publication, Ian Bezek held a long position in JNJ stock. Seeking Alpha - Value stocks are distinguished by lower-than-average price/book and price/earnings ratios. 6 days ago The Vanguard Dividend Appreciation ETF tracks the performance of the NASDAQ U.S. Dividend Achievers Select Index. Stocks that are quantitatively similar to JNJ, based on their financial statements, market capitalization, and price volatility, are WMT , JPM , MA , PG , and UNH . All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Since my June story, the … Since my June story, the … Johnson & Johnson Vs. If price volatilty is something you're paying attention to when building your dividend portfolio, know that JNJ has less fluctuation in its price than 99.67% of stocks we're observing. Find the latest Johnson & Johnson (JNJ) stock quote, history, news and other vital information to help you with your stock trading and investing. In terms of volatility of its share price, JNJ is more volatile than merely 0.11% of stocks we're observing. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Some of its well-known brands include Tylenol-fever, Listerine-bad breath, Splenda-no-calorie sweetener, Neutrogena-skin care, Pepcid-heartburn, Zyrtec - allergy, Motrin-ibuprofen, Sudafed-allergy, and plenty more. JNJ: Get the latest Johnson & Johnson stock price and detailed information including JNJ news, historical charts and realtime prices. JNJ has a market capitalization of $416,836,806,684 -- more than approximately 99.77% of US stocks. Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Just enter your email address below. Competition for Vaccine Pfizer and BioNTech face competition from Johnson & Johnson (NYSE:JNJ) and AstraZeneca (NYSE:AZN). Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. VIR AMGN MRNA JNJ IONS ABUS IONIS NVS ARWR ALNY 41 View daily, weekly or monthly format back to when Johnson & Johnson stock was issued. 2020 was a roller-coaster ride for investors, but these top stocks could help you sail smoother in 2021. In terms of volatility of its share price, JNJ is more volatile than merely 0.11% of stocks we're observing. JNJ's went public 35.04 years ago, making it older than 92.85% of listed US stocks we're tracking. 10 2. To help you reduce price risk in your dividend portfolio, here are the dividend stocks that are least correlated with JNJ's price: RAND , PBF , ES , OFED and ENR .